Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis

Jeffrey S. Upperman, Douglas Potoka, Anatoly Grishin, David Hackam, Ruben Zamora, Henri Ford

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Necrotizing enterocolitis (NEC) is the leading intestinal emergency in premature infants. The underlying etiology of NEC remains elusive, but hypoxic conditions and early enteral feeding are consistently implicated as the main risk factors in the pathogenesis of NEC. We postulate that nitric oxide (NO) plays a key role as a molecular signaling "hub" in the generation of gut barrier failure in NEC. Clinical studies suggest that inflammatory cytokines and excessive NO production may contribute to the pathogenesis of NEC. One of the major challenges in defining the critical signaling pathways that lead to the development of NEC is the lack of specific biochemical markers that consistently delineate the early stages of NEC. Intestinal pathology and molecular markers derived from late-stage NEC represent end-stage findings and thus provide little insight into the early events that led to intestinal inflammation. Such markers may not represent viable therapeutic targets for the treatment or prevention of NEC. Therefore, novel strategies are needed to identify the patients at risk for NEC and define the clinically relevant molecules that characterize the early stages of NEC. This review will examine the mechanisms of NO-mediated gut barrier failure and propose novel genetic-based approaches for elucidating the critical molecular pathways in NEC.

Original languageEnglish (US)
Pages (from-to)159-166
Number of pages8
JournalSeminars in Pediatric Surgery
Volume14
Issue number3
DOIs
StatePublished - Aug 1 2005
Externally publishedYes

Fingerprint

Necrotizing Enterocolitis
Nitric Oxide
Critical Pathways
Molecular Pathology
Enteral Nutrition
Premature Infants
Emergencies
Biomarkers

Keywords

  • Gene polymorphism
  • Intestinal inflammation
  • Micro array
  • Necrotizing enterocolitis
  • Nitric oxide
  • Sepsis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. / Upperman, Jeffrey S.; Potoka, Douglas; Grishin, Anatoly; Hackam, David; Zamora, Ruben; Ford, Henri.

In: Seminars in Pediatric Surgery, Vol. 14, No. 3, 01.08.2005, p. 159-166.

Research output: Contribution to journalArticle

Upperman, Jeffrey S. ; Potoka, Douglas ; Grishin, Anatoly ; Hackam, David ; Zamora, Ruben ; Ford, Henri. / Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. In: Seminars in Pediatric Surgery. 2005 ; Vol. 14, No. 3. pp. 159-166.
@article{9447a2e1eb2c4c008fdeb5bbd015f9bd,
title = "Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis",
abstract = "Necrotizing enterocolitis (NEC) is the leading intestinal emergency in premature infants. The underlying etiology of NEC remains elusive, but hypoxic conditions and early enteral feeding are consistently implicated as the main risk factors in the pathogenesis of NEC. We postulate that nitric oxide (NO) plays a key role as a molecular signaling {"}hub{"} in the generation of gut barrier failure in NEC. Clinical studies suggest that inflammatory cytokines and excessive NO production may contribute to the pathogenesis of NEC. One of the major challenges in defining the critical signaling pathways that lead to the development of NEC is the lack of specific biochemical markers that consistently delineate the early stages of NEC. Intestinal pathology and molecular markers derived from late-stage NEC represent end-stage findings and thus provide little insight into the early events that led to intestinal inflammation. Such markers may not represent viable therapeutic targets for the treatment or prevention of NEC. Therefore, novel strategies are needed to identify the patients at risk for NEC and define the clinically relevant molecules that characterize the early stages of NEC. This review will examine the mechanisms of NO-mediated gut barrier failure and propose novel genetic-based approaches for elucidating the critical molecular pathways in NEC.",
keywords = "Gene polymorphism, Intestinal inflammation, Micro array, Necrotizing enterocolitis, Nitric oxide, Sepsis",
author = "Upperman, {Jeffrey S.} and Douglas Potoka and Anatoly Grishin and David Hackam and Ruben Zamora and Henri Ford",
year = "2005",
month = "8",
day = "1",
doi = "10.1053/j.sempedsurg.2005.05.004",
language = "English (US)",
volume = "14",
pages = "159--166",
journal = "Seminars in Pediatric Surgery",
issn = "1055-8586",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis

AU - Upperman, Jeffrey S.

AU - Potoka, Douglas

AU - Grishin, Anatoly

AU - Hackam, David

AU - Zamora, Ruben

AU - Ford, Henri

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Necrotizing enterocolitis (NEC) is the leading intestinal emergency in premature infants. The underlying etiology of NEC remains elusive, but hypoxic conditions and early enteral feeding are consistently implicated as the main risk factors in the pathogenesis of NEC. We postulate that nitric oxide (NO) plays a key role as a molecular signaling "hub" in the generation of gut barrier failure in NEC. Clinical studies suggest that inflammatory cytokines and excessive NO production may contribute to the pathogenesis of NEC. One of the major challenges in defining the critical signaling pathways that lead to the development of NEC is the lack of specific biochemical markers that consistently delineate the early stages of NEC. Intestinal pathology and molecular markers derived from late-stage NEC represent end-stage findings and thus provide little insight into the early events that led to intestinal inflammation. Such markers may not represent viable therapeutic targets for the treatment or prevention of NEC. Therefore, novel strategies are needed to identify the patients at risk for NEC and define the clinically relevant molecules that characterize the early stages of NEC. This review will examine the mechanisms of NO-mediated gut barrier failure and propose novel genetic-based approaches for elucidating the critical molecular pathways in NEC.

AB - Necrotizing enterocolitis (NEC) is the leading intestinal emergency in premature infants. The underlying etiology of NEC remains elusive, but hypoxic conditions and early enteral feeding are consistently implicated as the main risk factors in the pathogenesis of NEC. We postulate that nitric oxide (NO) plays a key role as a molecular signaling "hub" in the generation of gut barrier failure in NEC. Clinical studies suggest that inflammatory cytokines and excessive NO production may contribute to the pathogenesis of NEC. One of the major challenges in defining the critical signaling pathways that lead to the development of NEC is the lack of specific biochemical markers that consistently delineate the early stages of NEC. Intestinal pathology and molecular markers derived from late-stage NEC represent end-stage findings and thus provide little insight into the early events that led to intestinal inflammation. Such markers may not represent viable therapeutic targets for the treatment or prevention of NEC. Therefore, novel strategies are needed to identify the patients at risk for NEC and define the clinically relevant molecules that characterize the early stages of NEC. This review will examine the mechanisms of NO-mediated gut barrier failure and propose novel genetic-based approaches for elucidating the critical molecular pathways in NEC.

KW - Gene polymorphism

KW - Intestinal inflammation

KW - Micro array

KW - Necrotizing enterocolitis

KW - Nitric oxide

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=23444452207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444452207&partnerID=8YFLogxK

U2 - 10.1053/j.sempedsurg.2005.05.004

DO - 10.1053/j.sempedsurg.2005.05.004

M3 - Article

VL - 14

SP - 159

EP - 166

JO - Seminars in Pediatric Surgery

JF - Seminars in Pediatric Surgery

SN - 1055-8586

IS - 3

ER -